top of page

Society of Toxicology Annual Meeting

March 10-14, 2019


Meet NeuCyte at SOT 2019 and See How Our Technology can Enable Your CNS Drug Discovery and Safety Assessment

Join our exhibitor session

 Building Confidence in Neurotoxicity Testing Using an In Vitro Phenotypic Assay Platform Based on Human iPSC-Derived Neurons

Date: March 12th 

Time: 12:00pm - 1:00pm

Room: 338

Lunch will be provided

shafer 1.jpg

Timothy Shafer, PhD

Research Toxicologist, US EPA 

30 years experience in neurotoxicology

head shot_DH.jpg

Daniel Haag, PhD

CSO, NeuCyte

Assessment of neuroactive effects of chemicals in cell-based assays remains challenging as complex functional tissue is required for biologically relevant readouts. A powerful assay platform can be built from highly functional, rapid maturating, fully defined neural co-cultures with a phenotypic approach. During this session, Dr Shafer and Dr Haag will present studies on the predictive power of such an in vitro system when combined with high sensitivity high throughput microelectrode array (MEA), demonstrating the utility of this direct-differentiated human model for neurotoxicity assessment.  

View our scientific posters


#1347/ P402

Comparison of Acute Effects of Neurotoxic Compounds on Network Activity in Human and Rodent Neural Cultures 


Author-Attended Time Block: 

Daniel Haag

3-11-2019 9:15AM to 10:45AM

#1333/ P388

Functional Characterization of Neural Network Activity in Human iPSC-Derived Neuron/Glial Co-Cultures

Author-Attended Time Block:

Touhidul Molla

3-11-2019 9:15AM to 10:45AM

Visit our booth #3655 and chat with our CNS drug discovery and safety assessment experts

bottom of page